Company
Cleara Biotech
- Biotech
- Location:
- CM Utrecht (Utrecht, Netherlands)
Description
Cleara Biotech develops peptide-based therapeutics and biomarkers to selectively eliminate p53-impaired cancer cells, producing D-amino acid peptide development candidates for solid tumors and hematological malignancies.
Related
ONK TherapeuticsONK Therapeutics develops off-the-shelf, optimally engineered natural killer (NK) cell therapies combining CAR and TRAIL variant constructs…
ThelperThelper develops first-in-class antiviral antibody drug conjugates (ADCs) targeting virally encoded biomarkers in aggressive solid tumors…
Gate2BrainGate2Brain develops peptide-based delivery technologies that transport therapeutics across biological barriers for applications including…
Iovance Biotherapeutics ($IOVA)Iovance Biotherapeutics develops and manufactures tumor-infiltrating lymphocyte (TIL) cell therapies for treating solid tumors, running…
Arsenal BioArsenal Bio develops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity,…
NanoPhoriaNanoPhoria develops inhalable Nano-in-Micro delivery formulations to enable tissue-directed delivery of therapeutic peptides and RNAs for…
Legend Biotech ($LEGN)Legend Biotech develops CAR-T cell therapies targeting blood cancers and solid tumors, advancing cellular research to expand treatment…
march.biosciencesmarch.biosciences develops CAR T‑cell therapies targeting difficult hematological cancers, advancing clinical-stage products and…
Generate:BiomedicinesGenerate:Biomedicines designs and engineers therapeutic proteins and cell therapies by combining machine learning with biological…
TILT BiotherapeuticsTILT Biotherapeutics develops oncolytic viral immunotherapies that modify the tumor microenvironment to stimulate T‑cell responses and…
OncoGenOncoGen conducts research and microproduction for cancer, allergies and regenerative medicine, developing gene‑cell therapies, anti‑cancer…
Vivere OncotherapiesVivere Oncotherapies develops bioengineered cancer immunotherapies designed to help patients’ immune systems target cold tumors and support…